Kusuri No Aoki Holdings Co., Ltd.

3549.T
Pharmaceutical Retailers
2026/01/16 Updated
Market Cap: $2.9B (¥453.1B)
Stock Price: $30.11 (¥4,771)
Exchange Rate: 1 USD = ¥158.48

Notice Regarding the Status and Completion of Treasury Stock Acquisition and the Decision on Matters Related to New Treasury Stock Acquisition (Acquisition of Treasury Stock Based on the Provisions of Article 459, Paragraph 1 of the Companies Act)

Kusuri no Aoki Holdings Co., Ltd. acquired 163,400 shares of treasury stock for a total price of 637,186,600 yen between December 1 and December 8, 2025, and established a new acquisition framework after the completion of the acquisition.

Importance:
Page Updated: December 25, 2025
IR Disclosure Date: December 25, 2025
Share Buyback
Capital Policy

Key Figures

  • Number of shares acquired: 163,400 shares
  • Acquisition price: 637,186,600 yen
  • Acquisition period: 2025-12-01 to 2025-12-08
  • Purpose of acquisition: Enhancement of shareholder returns and execution of flexible capital policy responsive to the management environment

AI要約

Overview of Treasury Stock Acquisition

Kusuri no Aoki Holdings Co., Ltd. acquired 163,400 shares of its common stock through market purchases on the Tokyo Stock Exchange during the period from December 1, 2025, to December 8, 2025, with a total acquisition price of 637,186,600 yen. As a result, all treasury stock acquisitions based on the previous treasury stock acquisition resolution have been completed. Furthermore, at the Board of Directors meeting held on July 3, 2025, the upper limit of the number of shares to be acquired was set at 6,000,000 shares, the upper limit of the acquisition price was set at 22,000,000,000 yen, and the acquisition period was set from July 4, 2025, to June 30, 2026.

Background and Purpose of Acquisition

The treasury stock acquisition is conducted to enhance shareholder returns and to execute flexible capital policy responsive to the management environment. By setting a new treasury stock acquisition framework, the company intends to continue improving capital efficiency through market purchases and deploy a flexible capital policy.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.